³í¹®) Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients
°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø Áø´Ü°Ë»çÀÇÇаú ¿ÀÀºÁö ±³¼ö(»çÁø ñ§, °øµ¿ ±³½ÅÀúÀÚ), ½ÅÀå³»°ú Á¤º´ÇÏ ±³¼ö(ñé, °øµ¿ ±³½ÅÀúÀÚ), ºÎõ¼º¸ðº´¿ø ½ÅÀå³»°ú ¹ÎÁö¿ø ±³¼ö(éÓ, °øµ¿ Á¦1ÀúÀÚ), °¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿ø Áø´Ü°Ë»çÀÇÇаú ÀÌÇý¿µ ±³¼ö(°øµ¿ Á¦1ÀúÀÚ) °øµ¿ ¿¬±¸ÆÀ